Neurocrine Biosciences
NBIX
#1657
Rank
$8.03 B
Marketcap
$84.12
Share price
1.56%
Change (1 day)
-11.08%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Revenue for Neurocrine Biosciences (NBIX)

Revenue in 2021 (TTM): $1.13 B

According to Neurocrine Biosciences 's latest financial reports the company's current revenue (TTM) is $1.13 B. In 2020 the company made a revenue of $1.04 B an increase over the years 2019 revenue that were of $0.78 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Neurocrine Biosciences from 2001 to 2021

Year Revenue Change
2021 (TTM)$1.13 B8.38%
2020$1.04 B32.71%
2019$0.78 B74.65%
2018$0.45 B
2013$2.91 M-91.48%
2012$0.03 B-55.77%
2011$0.07 B131.08%
2010$0.03 B1034.47%
2009$2.95 M-25.71%
2008$3.97 M224.75%
2007$1.22 M-96.88%
2006$0.03 B-68.33%
2005$0.12 B45.45%
2004$0.08 B-38.76%
2003$0.13 B670.73%
2002$0.01 B-56.25%
2001$0.04 B